Skip to content
Use caution Medical device recall · FDA · Published February 3, 2026

IBA Proton Therapy System PROTEUS 235 Recall: Risk of Mistreatment Without Safety Check

IBA recalls PROTEUS 235 proton therapy systems where safety checks may fail if external gating devices are disconnected. Affected units have specific serial numbers. Contact IBA for details.

🇺🇸 FDA recall #Z-1497-2026Medical deviceIon Beam Applications ›
Take action

Contact the company

Recalling firmIon Beam Applications S.A.Chemin Du Cyclotron 3 · Ottignies-Louvain-La-Neuve, Belgium
✎ GovInfoNow plain-language explainer

IBA is recalling PROTEUS 235 proton therapy systems because a safety feature might not stop the beam if an external device loses connection. This could cause incorrect treatment if the system isn't properly monitored. Read more at govinfonow.com/recall/50056-iba-proton-therapy-system-proteus-235-recall-risk-of-mistreatment.

Source Summary by GovInfoNow · govinfonow.com/recall/50056-iba-proton-therapy-system-proteus-235-recall-risk-of-mistreatment · Updated August 10, 2026 · FDA enforcement record: FDA #Z-1497-2026

Cite this page

“IBA Proton Therapy System PROTEUS 235 Recall: Risk of Mistreatment Without Safety Check.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/50056-iba-proton-therapy-system-proteus-235-recall-risk-of-mistreatment. Based on FDA recall #Z-1497-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1497-2026%22&limit=1).

The FDA announced on Feb. 3, 2026, that Ion Beam Applications S.A. is recalling its IBA Proton Therapy System - PROTEUS 235 because the Therapy Safety System may fail to interrupt beam delivery if an external gating signal is lost. This defect poses a risk of mistreatment for patients undergoing therapy.

How to tell if you have it

  • Brand: Ion Beam Applications
  • Product: IBA Proton Therapy System - PROTEUS 235
  • Model: PROTEUS 235
  • UDI-DI: 05404013801138
  • Serial Numbers: SBF103 (JP), SBF124 (EU), SBF133 (US), SBF140 (EU)
  • Distribution: Worldwide, including Florida, Italy, and Japan

The hazard

The Universal Beam Triggering Interface is disabled in the Therapy Safety System configuration. Consequently, the system does not interrupt beam delivery if the Healthy Signal from an external gating device is lost, which may lead to a risk of mistreatment when external gating devices are used.

Context

GovInfoNow's records show Ion Beam Applications S.A. has 21 other recalls on record since Oct. 17, 2017. Other recent recalls of similar products include the Elekta MOSAIQ Oncology System Recall (Dec. 10, 2025), the Hitachi Proton Beam Therapy System Recall (Feb. 6, 2026), and the GE Medical Systems Israel SMV BodyTrack Nuclear Medicine Systems Recall (Dec. 10, 2025).

How to tell if you have this one

Check for serial numbers SBF103 (Japan), SBF124 (Europe), SBF133 (US), or SBF140 (Europe) on the PROTEUS 235 system. The product was sold with specific UDI-DI codes.

  • Brand
    Ion Beam Applications
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Safety Settings

    Ensure the external gating device is connected and functioning properly before each therapy session.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide - US Nationwide distribution in the state of FL and the countries of Italy and Japan.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 43 days after the firm started it.

1. Firm started the recall: Feb 3, 202612. FDA classified it Class II: Mar 6, 202623. Published in FDA’s Enforcement Report: Mar 18, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this recall dangerous?

The recall addresses a potential risk of incorrect treatment if the safety feature fails during therapy, but it does not indicate immediate danger to users.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1497-2026 (February 3, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1497-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA